Spectrum of susceptibility to rejection of heart and multivisceral small bowel allografts using leflunomide immunosuppression.
D'Silva
M
M
Transplantation Microsurgery Laboratory, Queen Elizabeth Hospital, University of Birmingham, Edgbaston, United Kingdom.
DeRoover
A
A
Nishimura
Y
Y
Antoniou
E
E
Candinas
D
D
Hubscher
S G
SG
McMaster
P
P
D000818:Animals; D004198:Disease Susceptibility; D006084:Graft Rejection / Q000473:pathology* / Q000517:prevention & control*; D016027:Heart Transplantation / Q000276:immunology / Q000473:pathology / Q000502:physiology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007421:Intestine, Small / Q000473:pathology / Q000637:transplantation*; D007555:Isoxazoles / Q000627:therapeutic use*; D000077339:Leflunomide; D009200:Myocardial Contraction; D016035:Pancreas Transplantation / Q000276:immunology / Q000473:pathology / Q000502:physiology*; D051381:Rats; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D014184:Transplantation, Homologous / Q000276:immunology / Q000473:pathology / Q000502:physiology*
D007166:Immunosuppressive Agents; D007555:Isoxazoles; D000077339:Leflunomide